Santhera Pharmaceuticals AG (SPHDF) on Monday said the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended expanding the use of AGAMREE to treat children as young as two years old with Duchenne muscular dystrophy.
AGAMREE is currently approved in the European Union for patients aged four and older.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.